Pfizer posts 4Q loss, misses Street views, on lower revenue
NEW YORK --- Pfizer's ongoing restructuring is significantly reducing revenue, resulting in a $337 million loss in its fourth quarter and a slight miss of Wall Street's profit expe…
NEW YORK --- Pfizer's ongoing restructuring is significantly reducing revenue, resulting in a $337 million loss in its fourth quarter and a slight miss of Wall Street's profit expe…